Sort   by:  
 Page size 
ProteomicsRelative quantitative proteomics of uninfected vs wMel infected Aedes aegypti midguts
Wolbachia are intracellular maternally inherited bacteria that can spread through insect populations and block virus transmission by mosquitoes, providing an important new dengue control strategy. To better understand the mechanisms of virus inhibition, proteomic quantification of the effects of Wol...
ORGANISM(S): Aedes aegypti Wolbachia pipientis wMelCS 
2017-09-19 | PXD006239 | Pride
Wolbachia Ae. aegypti Tmt Wmel Aedes aegypti 
ProteomicsProteomic comparison of uninfected and wMelPop infected Aag2 cells
Wolbachia endosymbionts are widespread intracellular, maternally inherited bacteria which manipulate the host to favour their spread through a population. Cytoplasmic incompatibility (CI) and viral suppression are two such manipulations driven by uncharacterised mechanisms. To gain insight into pote...
ORGANISM(S): Aedes aegypti 
2017-09-19 | PXD003429 | Pride
Wolbachia Offgel Dimethyl Aag2 Wmelpop Mass spectrometry Cholesterol Walbb Aedes aegypti Cytoplasmic incompatibility 
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of DLD-1 and MDA-MB-231 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset also includes DLD-1 cells treated with FT671 (USP7 inhibitor) at 10 µM for 30 min and 6 h.Sample IDs:#1-5 Control 30 ...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD073869 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of DLD-1 and MDA-MB-231 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset also includes DLD-1 cells treated with FT671 (USP7 inhibitor) at 10 µM for 30 min and 6 h. Sample IDs: #1-5 Control 3...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD075275 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
K-GG ubiquitin profiling of SK-MEL-2 and UO-31 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset is the matched global quantitative proteomics data.Sample IDs:#1-5 Control 30 min UO-31#6-10 WEHI-092 30 min UO-31#11-1...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD073798 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
Global proteomics experiment using USP9X siRNA (and control) MDA-MB-231 cells with (10 µM, 24 h) and without USP9X inhibitor treatment using WEHI-092 and untreated (DMSO) control (P5448, see sample key). Global proteomics experiment profiling cancer cell lines treated with USP9X inhibitor WEHI-092 (...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD062674 | Pride
ProteomicsGlobal analysis of cancer cell responses to USP9X inhibition
Global proteomics dataset for K-GG ubiquitin profiling of DLD-1 and MDA-MB-231 cells treated with the selective USP9X inhibitor WEHI-092 at 10 µM for 30 min, 6 h, and 24 h (and DMSO-treated control). This dataset also includes DLD-1 cells treated with FT671 (USP7 inhibitor) at 10 µM for 30 min and 6...
ORGANISM(S): Homo sapiens (Human) 
2026-04-09 | PXD074673 | Pride
Sort   by:  
 Page size